Comment by
Sunvalley on Sep 29, 2020 5:04pm
Nice read you say?? Chemistry was never my forte during my learning years. After reading the submission in detail I felt compelled to go out on my front lawn and do cartwheels and with each revolution I consumed a mouthful of grass LOL
Comment by
Hempdoc on Sep 29, 2020 5:19pm
Thanks for posting...more sweet validation as our pharmaceutical "assets" continue to grow/excite, not to mention the sweet glitter of osmium to end the day....TLT has it covered : ).
Comment by
Eoganacht on Sep 29, 2020 5:41pm
That's a gooden. Hopefully Theralase will get to Os-4T eventually. But whether or not, the research still increases Theralase's IP. "Here we introduce an Os(II)-based PS (Os-4T) that is extremely potent, can be activated with near-infrared light (NIR, 733 nm), and exhibits photocytotoxic effects in hypoxia (1% O2)."
Comment by
investclub on Sep 29, 2020 8:36pm
Thanks enriquesuave Quite mind boggling to read but what I did grasp is the incredible amount of work has gone into developing not only TDL-1433 but to try and get my mind around this possible new improved compound . Yes amazing is an understatement.